通过抑制胆固醇酯转运蛋白来提高高密度脂蛋白胆固醇：一条崎岖之路及经验教训？dal-HEART项目的早期夭折。 - Suppr

Suppr

超能文献

Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme.

作者信息

Landmesser Ulf, von Eckardstein Arnold, Kastelein John, Deanfield John, Lüscher Thomas F

出版信息

Eur Heart J. 2012 Jul;33(14):1712-5. doi: 10.1093/eurheartj/ehs182. Epub 2012 Jun 13.

DOI:10.1093/eurheartj/ehs182

PMID:22696435

Abstract

摘要

相似文献

Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme.通过抑制胆固醇酯转运蛋白来提高高密度脂蛋白胆固醇：一条崎岖之路及经验教训？dal-HEART项目的早期夭折。

Eur Heart J. 2012 Jul;33(14):1712-5. doi: 10.1093/eurheartj/ehs182. Epub 2012 Jun 13.

[HDL and CETP in atherogenesis].[高密度脂蛋白与胆固醇酯转运蛋白在动脉粥样硬化发生中的作用]

Dtsch Med Wochenschr. 2010 Feb;135(5):188-92. doi: 10.1055/s-0030-1247862. Epub 2010 Jan 15.

Future of cholesteryl ester transfer protein inhibitors.胆固醇酯转移蛋白抑制剂的未来。

Annu Rev Med. 2014;65:385-403. doi: 10.1146/annurev-med-050311-163305.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.近期急性冠脉综合征患者应用达塞曲匹的效果。

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.不同降低胆固醇酯转移蛋白活性的化合物对脂蛋白代谢的影响。

Curr Opin Lipidol. 2011 Aug;22(4):288-95. doi: 10.1097/MOL.0b013e3283475e00.

Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?在通过提高高密度脂蛋白和抑制胆固醇酯转运来降低心脏病风险方面，我们目前进展如何？

Curr Opin Cardiol. 2007 Jul;22(4):373-8. doi: 10.1097/HCO.0b013e3281fbd3c7.

Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.靶向胆固醇酯转移蛋白用于心血管疾病的预防和管理。

J Am Coll Cardiol. 2006 Feb 7;47(3):492-9. doi: 10.1016/j.jacc.2005.09.042. Epub 2006 Jan 18.

Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.从调查脂质水平管理以了解其对动脉粥样硬化事件影响的研究（ILLUMINATE 试验）中吸取的经验教训。

Am J Cardiol. 2009 Nov 16;104(10 Suppl):10E-5E. doi: 10.1016/j.amjcard.2009.09.014.

Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?胆固醇酯转移蛋白抑制剂对人体脂蛋白代谢的影响：为何它们未能降低冠心病风险？

Curr Opin Lipidol. 2013 Jun;24(3):259-64. doi: 10.1097/MOL.0b013e3283612454.

Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?胆固醇酯转移蛋白抑制剂降低心血管风险：我们现在在哪里？

Trends Pharmacol Sci. 2011 Dec;32(12):694-9. doi: 10.1016/j.tips.2011.07.004. Epub 2011 Nov 14.

引用本文的文献

Threshold effect of non-high-density lipoprotein to high-density lipoprotein cholesterol ratio and hypertension in U.S. adults: NHANES 2005-2016.美国成年人中非高密度脂蛋白与高密度脂蛋白胆固醇比值和高血压的阈值效应：2005 - 2016年美国国家健康与营养检查调查（NHANES）

Medicine (Baltimore). 2025 Feb 21;104(8):e41585. doi: 10.1097/MD.0000000000041585.

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.重组高密度脂蛋白（rHDL）对急性冠状动脉综合征患者循环CD34 +细胞的有益作用

PLoS One. 2017 Jan 6;12(1):e0168448. doi: 10.1371/journal.pone.0168448. eCollection 2017.

ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.家族性高胆固醇血症患者高密度脂蛋白中的载脂蛋白L1水平与心血管事件表现

J Lipid Res. 2016 Jun;57(6):1059-73. doi: 10.1194/jlr.P061598. Epub 2016 Apr 25.

Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements.儿童肥胖相关的内皮功能障碍：病理生理机制与诊断进展的最新情况

Pediatr Res. 2016 Jun;79(6):831-7. doi: 10.1038/pr.2016.22. Epub 2016 Feb 11.

Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.冠状动脉粥样硬化中的炎症治疗靶点：从分子生物学到临床应用。

Front Physiol. 2014 Nov 21;5:455. doi: 10.3389/fphys.2014.00455. eCollection 2014.

Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.基于高密度脂蛋白胆固醇与载脂蛋白 A-I 比值估算的高密度脂蛋白颗粒大小对稳定型冠状动脉疾病糖尿病患者短期预后的影响。

J Geriatr Cardiol. 2014 Sep;11(3):245-52. doi: 10.11909/j.issn.1671-5411.2014.03.015.

HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.高密度脂蛋白胆固醇亚类、心肌梗死与二级预防中的死亡率：脂蛋白研究人员协作组

Eur Heart J. 2015 Jan 1;36(1):22-30. doi: 10.1093/eurheartj/ehu264. Epub 2014 Jun 30.

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.抗银屑病治疗可恢复高密度脂蛋白组成和功能。

J Invest Dermatol. 2014 Mar;134(3):635-642. doi: 10.1038/jid.2013.359. Epub 2013 Aug 28.

In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.安塞曲匹对前β-HDL 的体内作用：改善 HDL 重塑而不影响胆固醇吸收。

J Lipid Res. 2013 Oct;54(10):2858-65. doi: 10.1194/jlr.M041541. Epub 2013 Jul 29.

Aging affects high-density lipoprotein composition and function.衰老会影响高密度脂蛋白的组成和功能。

Biochim Biophys Acta. 2013 Sep;1831(9):1442-8. doi: 10.1016/j.bbalip.2013.06.004. Epub 2013 Jun 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验